Different patients, different stories

Presented by Pfizer, Inc.

Each patient who presents with a dermatological condition is unique – disease-related factors as well as differences in race, ethnicity, religion, gender, sexual orientation, health beliefs, and socioeconomic status should be taken into consideration when developing a patient’s care plan.1–4 The US population is becoming increasingly diverse: in 20 years, minorities will comprise more than half of the population.1,5 This growing diversity will require dermatologists to be more culturally competent in their daily practice to meet the needs of individual patients.4 

Join the Derm program for two engaging sessions and delve into unique patient stories conveying the importance of individualized management in atopic dermatitis (AD), alopecia areata (AA) and vitiligo.

Day One Premiere: Living With Alopecia Areata

Every patient with AA has a unique journey living with their disease and is impacted by the disease in different ways. And despite significant advances in understanding the complex underlying pathophysiology, the range of comorbidities, and patient impacts, AA is not always recognized as a medical disease.3,6,7

A disease with varied clinical presentations, severities, and comorbidities that range from atopic diseases to autoimmune diseases3,7 tells us that each patient’s experience with the disease is unique. However, all patients will have their own “Day One” – the first day living with AA, the day they are diagnosed, or the day they learn to accept their disease. 

In this Pfizer-sponsored Industry Non-CME (INC) Program, you will experience the premiere of the short film, Day One: Living With Alopecia Areata, which follows a day in the life of three patients with AA and explores how living with AA affects the fundamentals of modern life. Following the screening, a panel of experts will engage in discussions around the key messages of the film and share patient experiences from their own clinical practice. Experts will reflect on the timing of a patient’s Day One, and how it can impact patients differently at all aspects of life, and discuss the importance of classifying AA as a true medical disease to allow patients to access treatment and empower them to participate in shared decision making relating to their care.

Please join us for the premiere of the short film, Day One: Living With Alopecia Areata!

REGISTER YOUR INTEREST HERE.

When:  Friday 8th March | Registration & Dinner Time 6:30 PM | Program Start Time: 7:00 PM

Where: Harbor Ballroom GHI – Manchester Grand Hyatt San Diego

Expert Forum: Navigating the Spectrum of Skin Color in Dermatology

Imagine you are a patient, walking into the dermatology clinic for the first time. You may have mixed feelings about your first consultation with a dermatologist: relief, anxiety, or even skepticism. As you sit down in the waiting room, you glance at the people around you. What do you see? Some patients might look just like you. Others might have a different shade of skin. Some patients may speak a different language, come from a different racial background, or practice a different religion. Every patient sitting in the room is equally unique and has their own personal story with their disease. It is the role of the dermatologist to understand each patient’s experience in order to provide them with the best possible care. 

In this Pfizer-sponsored Industry Non-CME (INC) Program, a panel of experts will share considerations for managing patients with skin of color and diverse backgrounds and describe best practices for individualized patient care. For example, in diseases such as AD, patients with skin of color may have distinct clinical presentations that require a tailored approach to care.8 While in AA and vitiligo, patients may experience a significant quality-of-life impact that can be accentuated by their individual background, due to the significance of hair or skin color in their religion or culture.9–11 In all instances, individual patient management and cultural competence is critical to ensure the best possible outcomes.4

We hope that you will join us for this unique, interactive program!

REGISTER YOUR INTEREST HERE.

When: Saturday 9th March | Registration & Dinner Time 6:30 PM | Program Start Time: 7:00 PM

Where: Harbor Ballroom GHI – Manchester Grand Hyatt San Diego

References

  1. Desai SR, et al. Int J Womens Dermatol. 2021;7(4):378-82.
  2. Quan VL, et al. Am J Clin Dermatol. 2023;24(5):731-51.
  3. Korta DZ, et al. J Am Acad Dermatol. 2018;78(4):832–4. 
  4. Bilcha K. Cultural Competence in Dermatology (2021). https://practicaldermatology.com/articles/2021-oct/cultural-competence-in-dermatology?c4src=search:feed [Last accessed February 2024].
  5. Colby SL, Ortman JM. US Census Bureau. March 03, 2015. www.census.gov/library/publications/2015/demo/p25-1143.html [Last accessed February 2024]
  6. Aldhouse NVJ, et al. J Patient Rep Outcomes. 2020;4(1):76.
  7. Muntyanu, A, et al. J Eur Acad Dermatol Venereol. 2023;37:1490–520.
  8. Adawi W, et al. Dermatol Clin. 2023;41(3):417-29.
  9. Meister H, Silverberg NB. JAAD Case Rep. 2020;7:113–6. 
  10. Jones NL, Heath CR. Pediatr Dermatol. 2021;38 Suppl 2:158–60.
  11. Harris J. Nature. 2018;563(7732):S99.

Derm is a medical education program being developed for healthcare professionals only and is organized by Pfizer. This program is independent and is not part of the official AAD Annual Meeting, as planned by its Scientific Assembly Committee. This program does not qualify for Continuing Medical Education (CME) Credit. PP-UNP-USA-3426 ©2024 Pfizer Inc. All rights reserved. February 2024.